The identification of JMJD6 as a novel biomarker for colon cancer prognosis and a target for novel therapeutic interventions warrants further study to elucidate the molecular mechanisms of its activity regulation and its biological functions. This evidence concerns the gene JMJD6 and colonic neoplasm.